{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:46:55Z","timestamp":1786996015057,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T00:00:00Z","timestamp":1751760000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostate International"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.prnil.2025.07.001","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:41:33Z","timestamp":1752626493000},"page":"239-245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["18F-florastamin positron emission tomography\/computed tomography in men with clinical suspicion of prostate cancer: A phase I prospective study"],"prefix":"10.1016","volume":"13","author":[{"given":"Sonya Y.","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyong Woo","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chansoo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Yoon","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ie Ryung","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Yeol","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prnil.2025.07.001_bib1","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.urolonc.2018.11.021","article-title":"Reducing unnecessary biopsies while detecting clinically significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore","volume":"37","author":"Verbeek","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.prnil.2025.07.001_bib2","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.prnil.2025.07.001_bib3","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prnil.2025.07.001_bib4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00259-016-3490-6","article-title":"Comparison of","volume":"44","author":"Schwenck","year":"2017","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.prnil.2025.07.001_bib5","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2967\/jnumed.118.224543","article-title":"Intention-to-Treat analysis of","volume":"60","author":"Schwenck","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prnil.2025.07.001_bib6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2967\/jnumed.118.220541","article-title":"Detection rate of","volume":"60","author":"Jilg","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prnil.2025.07.001_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00259-013-2525-5","article-title":"Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET\/CT for the diagnosis of recurrent prostate cancer","volume":"41","author":"Afshar-Oromieh","year":"2014","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.prnil.2025.07.001_bib8","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S1470-2045(19)30415-2","article-title":"F-fluciclovine PET-CT and","volume":"20","author":"Calais","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prnil.2025.07.001_bib9","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/RLU.0000000000002210","article-title":"Therapeutic responses and survival effects of 177Lu-PSMA-617 radioligand therapy in metastatic castrate-resistant prostate cancer: a meta-analysis","volume":"43","author":"Kim","year":"2018","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.prnil.2025.07.001_bib10","doi-asserted-by":"crossref","first-page":"9364","DOI":"10.7150\/thno.48107","article-title":"Efficacy and safety of","volume":"10","author":"Yadav","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.prnil.2025.07.001_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00259-017-3817-y","article-title":"Targeted alpha therapy of mCRPC: dosimetry estimate of","volume":"45","author":"Kratochwil","year":"2018","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.prnil.2025.07.001_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4111\/icu.20230106","article-title":"The era of prostate-specific membrane antigen for the diagnosis and treatment of prostate cancer: a novel horizon","volume":"64","author":"Song","year":"2023","journal-title":"Investig Clin Urol"},{"key":"10.1016\/j.prnil.2025.07.001_bib13","doi-asserted-by":"crossref","first-page":"786","DOI":"10.2967\/jnumed.118.219501","article-title":"Metaanalysis of","volume":"60","author":"Hope","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prnil.2025.07.001_bib14","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nrurol.2016.136","article-title":"Imaging: PSMA PET-CT in initial prostate cancer staging","volume":"13","author":"Verburg","year":"2016","journal-title":"Nat Rev Urol"},{"issue":"1","key":"10.1016\/j.prnil.2025.07.001_bib15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41391-020-00270-8","article-title":"Diagnostic ability of Ga-68 PSMA PET to detect dominant and non-dominant tumors, upgrading and adverse pathology in patients with PIRADS 4-5 index lesions undergoing radical prostatectomy","volume":"24","author":"Koseoglu","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.prnil.2025.07.001_bib16","first-page":"1","volume":"45","year":"2018","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.prnil.2025.07.001_bib17","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1200\/JCO.2020.38.15_suppl.5501","article-title":"Impact of PSMA-targeted imaging with 18F-DCFPyL-PET\/CT on clinical management of patients (pts) with biochemically recurrent (BCR) prostate cancer (PCa): results from a phase III, prospective, multicenter study (CONDOR)","volume":"38","author":"Morris","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prnil.2025.07.001_bib18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.prnil.2022.08.004","article-title":"Irreversible electroporation for prostate cancer using PSMA PET-CT","volume":"11","author":"Shin","year":"2023","journal-title":"Prostate Int"},{"issue":"1","key":"10.1016\/j.prnil.2025.07.001_bib19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00259-020-04883-y","article-title":"A microdose clinical trial to evaluate [18F]Florastamin as a positron emission tomography imaging agent in patients with prostate cancer","volume":"48","author":"Lee","year":"2021","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.prnil.2025.07.001_bib20","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer","volume":"280","author":"D'Amico","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.prnil.2025.07.001_bib21","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.euf.2017.11.010","article-title":"Prostate magnetic resonance imaging interpretation varies substantially across radiologists","volume":"5","author":"Sonn","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.prnil.2025.07.001_bib22","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1148\/radiol.2016152542","article-title":"Interobserver reproducibility of the PI-RADS version 2 lexicon: a multicenter study of six experienced prostate radiologists","volume":"280","author":"Rosenkrantz","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.prnil.2025.07.001_bib23","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.eururo.2021.08.002","article-title":"The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): a prospective multicenter study","volume":"80","author":"Emmett","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.prnil.2025.07.001_bib24","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1007\/s00259-021-05355-7","article-title":"Detection of clinically significant prostate cancer with (18)F-DCFPyL PET\/multiparametric MR","volume":"48","author":"Metser","year":"2021","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.prnil.2025.07.001_bib25","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.231879","article-title":"Multiparametric MRI and (18)F-PSMA-1007 PET\/CT for the detection of clinically significant prostate cancer","volume":"311","author":"Priv\u00e9","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.prnil.2025.07.001_bib26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3348\/kjr.2023.0656","article-title":"Dosimetric analysis of a phase I study of PSMA-targeting radiopharmaceutical therapy with [(177)Lu]Ludotadipep in patients with metastatic castration-resistant prostate cancer","volume":"25","author":"Ha","year":"2024","journal-title":"Korean J Radiol"}],"container-title":["Prostate International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2287888225000625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2287888225000625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:39:09Z","timestamp":1773880749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2287888225000625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2287888225000625"],"URL":"https:\/\/doi.org\/10.1016\/j.prnil.2025.07.001","relation":{},"ISSN":["2287-8882"],"issn-type":[{"value":"2287-8882","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"18F-florastamin positron emission tomography\/computed tomography in men with clinical suspicion of prostate cancer: A phase I prospective study","name":"articletitle","label":"Article Title"},{"value":"Prostate International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prnil.2025.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Asian Pacific Prostate Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}